|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 154.80 EUR | -3.97% |
|
+0.51% | +32.60% |
| 04/08 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 03/08 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
| Market Cap | 12.98B 14.99B 12.13B 11.09B 20.89B 1,430B 21.22B 142B 55.82B 715B 56.3B 55.07B 2,382B | P/E 2026 * |
13.2x | P/E 2027 * | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11.75B 13.57B 10.98B 10.03B 18.91B 1,294B 19.21B 129B 50.52B 647B 50.95B 49.84B 2,156B | EV / Sales 2026 * |
2.58x | EV / Sales 2027 * | 2.35x |
| Free-Float |
40.65% | Yield 2026 * |
0.97% | Yield 2027 * | 0.97% |
Last Transcript: Ipsen
| 1 day | -3.60% | ||
| 1 week | +0.51% | ||
| Current month | -8.38% | ||
| 1 month | -3.38% | ||
| 3 months | -5.80% | ||
| 6 months | +13.24% | ||
| Current year | +32.60% |
| 1 week | 157.1 |  | 161.2 |
| 1 month | 153.8 | | 171.8 |
| Current year | 116.5 | | 172.7 |
| 1 year | 105.9 | | 172.7 |
| 3 years | 90.2 | | 172.7 |
| 5 years | 77.76 | | 172.7 |
| 10 years | 36.84 | | 172.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 01/07/2020 |
| Chief Executive Officer | 57 | 01/01/2020 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 30/08/2005 |
| Chairman | 68 | 22/11/2010 | |
Carol Xueref
BRD | Director/Board Member | 69 | 01/06/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.97% | +0.51% | - | - | 14.99B | |
| -1.31% | +9.72% | +92.71% | +131.72% | 1,098B | |
| -0.92% | +2.48% | +50.30% | +50.27% | 631B | |
| +0.27% | +1.72% | +24.85% | +62.96% | 438B | |
| -0.66% | +3.58% | +50.43% | +39.73% | 368B | |
| -0.65% | +1.73% | +32.01% | +39.63% | 298B | |
| -1.11% | +0.97% | +7.41% | +7.47% | 251B | |
| -0.90% | +6.40% | +45.57% | +58.09% | 226B | |
| +0.14% | -0.21% | -4.85% | -50.54% | 209B | |
| +1.17% | -0.76% | +11.41% | +67.78% | 165B | |
| Average | -0.72% | +1,657.21% | +34.43% | +45.24% | 409.37B | |
| Weighted average by Cap. | -0.70% | +1,331.50% | +50.36% | +66.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.55B 5.26B 4.26B 3.89B 7.33B 502B 7.44B 49.9B 19.58B 251B 19.75B 19.32B 836B | 4.57B 5.28B 4.27B 3.9B 7.36B 504B 7.47B 50.1B 19.66B 252B 19.83B 19.39B 839B |
| Net income | 1B 1.16B 936M 856M 1.61B 110B 1.64B 10.98B 4.31B 55.2B 4.34B 4.25B 184B | 960M 1.11B 898M 820M 1.55B 106B 1.57B 10.53B 4.13B 52.93B 4.17B 4.07B 176B |
| Net Debt | -1.23B -1.42B -1.15B -1.05B -1.98B -136B -2.02B -13.51B -5.3B -67.93B -5.35B -5.23B -226B | -2.24B -2.59B -2.09B -1.91B -3.61B -247B -3.66B -24.56B -9.64B -124B -9.72B -9.51B -411B |
| Date | Price | Change |
|---|---|---|
| 11/08/26 | EUR 157.40 | -2.36% |
| 10/08/26 | EUR 161.20 | +0.12% |
| 07/08/26 | EUR 161.00 | +1.32% |
| 06/08/26 | EUR 158.90 | +1.15% |
| 05/08/26 | EUR 157.10 | +0.32% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
- I7G Stock
Select your edition
All financial news and data tailored to specific country editions
